Structure |
Chemical Name |
CAS |
MF |
![2,3-ジクロロ-5,6-ジフェニルピラジン](/CAS/20200401/GIF/57038-62-7.gif) |
2,3-ジクロロ-5,6-ジフェニルピラジン |
57038-62-7 |
C16H10Cl2N2 |
![1-(3-アミノプロピル)-1-(4-フルオロフェニル)-1,3-ジヒドロ-5-イソベンゾフランカルボニトリル](/CAS/GIF/62498-69-5.gif) |
1-(3-アミノプロピル)-1-(4-フルオロフェニル)-1,3-ジヒドロ-5-イソベンゾフランカルボニトリル |
62498-69-5 |
C18H17FN2O |
![3-(3-ヒドロキシプロピルジチオ)プロパン-1-オール](/CAS/GIF/30453-21-5.gif) |
3-(3-ヒドロキシプロピルジチオ)プロパン-1-オール |
30453-21-5 |
C6H14O2S2 |
![N-(クロロアセチル)-L-プロリン](/CAS/GIF/23500-10-9.gif) |
N-(クロロアセチル)-L-プロリン |
23500-10-9 |
C7H10ClNO3 |
![2,4-ジヒドロ-4-[4-[4-(4-メトキシフェニル)-1-ピペラジニル]フェニル]-2-(1-メチルプロピル)-3H-1,2,4-トリアゾール-3-オン](/CAS/GIF/252964-68-4.gif) |
2,4-ジヒドロ-4-[4-[4-(4-メトキシフェニル)-1-ピペラジニル]フェニル]-2-(1-メチルプロピル)-3H-1,2,4-トリアゾール-3-オン |
252964-68-4 |
C23H29N5O2 |
![2-(2-メトキシフェノキシ)エタノール](/CAS/GIF/18181-71-0.gif) |
2-(2-メトキシフェノキシ)エタノール |
18181-71-0 |
C9H12O3 |
![2-(3-クロロ-2-ヒドロキシプロピル)-2H-イソインドール-1,3-ジオン](/CAS/20200401/GIF/19667-37-9.gif) |
2-(3-クロロ-2-ヒドロキシプロピル)-2H-イソインドール-1,3-ジオン |
19667-37-9 |
C11H10ClNO3 |
![4,6-ジブロモ-3-メチルフェノール](/CAS/GIF/13321-76-1.gif) |
4,6-ジブロモ-3-メチルフェノール |
13321-76-1 |
C7H6Br2O |
![デトミジン塩酸塩一水和物](/CAS/GIF/90038-00-9.gif) |
デトミジン塩酸塩一水和物 |
90038-00-9 |
C12H17ClN2O |
![メトプロロール酸エチルエステル](/CAS/GIF/29112-40-1.gif) |
メトプロロール酸エチルエステル |
29112-40-1 |
C16H25NO4 |
![6-Hydroxy Desloratadine](/CAS/GIF/119410-05-8.gif) |
6-Hydroxy Desloratadine |
119410-05-8 |
C19H19ClN2O |
![10-Acetyloxy Oxcarbazepine](/CAS/GIF/113952-21-9.gif) |
10-Acetyloxy Oxcarbazepine |
113952-21-9 |
C17H14N2O4 |
![9-[[2-(α-L-Alanyloxy)ethoxy]methyl]guanine Hydrochloride](/CAS/GIF/84499-63-8.gif) |
9-[[2-(α-L-Alanyloxy)ethoxy]methyl]guanine Hydrochloride |
84499-63-8 |
C11H17ClN6O4 |
![Irinotecan Impurity 26](/CAS/20210111/GIF/86639-51-2.gif) |
Irinotecan Impurity 26 |
86639-51-2 |
C22H20N2O5 |
![Bis(aminoethoxy) Amlodipine](/CAS2/GIF/721958-74-3.gif) |
Bis(aminoethoxy) Amlodipine |
721958-74-3 |
C22H30ClN3O6 |
![7,8,9,10-Dehydro Doxorubicinone](/CAS/GIF/1159977-23-7.gif) |
7,8,9,10-Dehydro Doxorubicinone |
1159977-23-7 |
C21H14O8 |
![4-TERT-ブチル-2,6-ジメチル-3-ヒドロキシフェニルアセトアミド(OXYMETAZOLINE IMPURITY)](/CAS/GIF/55699-13-3.gif) |
4-TERT-ブチル-2,6-ジメチル-3-ヒドロキシフェニルアセトアミド(OXYMETAZOLINE IMPURITY) |
55699-13-3 |
C14H21NO2 |
![(S)-N-Demethyl Dapoxetine](/CAS/GIF/147199-39-1.gif) |
(S)-N-Demethyl Dapoxetine |
147199-39-1 |
C20H21NO |
![Famotidine Related Compound A Hydrochloride](/CAS/GIF/76833-47-1.gif) |
Famotidine Related Compound A Hydrochloride |
76833-47-1 |
C8H15ClN6S2 |
![Des(trifluoroethyl) Lansoprazole Sulfide](/CAS/GIF/131926-97-1.gif) |
Des(trifluoroethyl) Lansoprazole Sulfide |
131926-97-1 |
C14H13N3OS |
![DESULFO AZTREONAM TRIFLUOROACETIC ACID SALT (CONTAINS 〜20% UNKNOWN INORGANIC SALTS)](/CAS/20200611/GIF/102579-59-9.gif) |
DESULFO AZTREONAM TRIFLUOROACETIC ACID SALT (CONTAINS 〜20% UNKNOWN INORGANIC SALTS) |
102579-59-9 |
C13H17N5O5S |
![(2S,3S,5S)-2-ヘキシル-3,5-ジヒドロキシヘキサデカン酸](/CAS2/GIF/130793-30-5.gif) |
(2S,3S,5S)-2-ヘキシル-3,5-ジヒドロキシヘキサデカン酸 |
130793-30-5 |
C22H44O4 |
![Mosapride Citric Amide](/CAS/GIF/1215825-20-9.gif) |
Mosapride Citric Amide |
1215825-20-9 |
C27H31ClFN3O9 |
![(1,2,4-Triazol-4-yl) Itraconazole](/CAS/GIF/854372-77-3.gif) |
(1,2,4-Triazol-4-yl) Itraconazole |
854372-77-3 |
C35H38Cl2N8O4 |
![6,7,8,9-Tetrahydro Carvedilol](/CAS/GIF/1246820-73-4.gif) |
6,7,8,9-Tetrahydro Carvedilol |
1246820-73-4 |
C24H30N2O4 |
![Cefdinir Lactone](/CAS/GIF/946573-41-7.gif) |
Cefdinir Lactone |
946573-41-7 |
C14H13N5O5S2 |
![Ozagrel methylester](/CAS/20180713/GIF/866157-50-8.gif) |
Ozagrel methylester |
866157-50-8 |
C13H12N2O2 |
![オルト-メトプロロール](/CAS/GIF/163685-38-9.gif) |
オルト-メトプロロール |
163685-38-9 |
C15H25NO3 |
![TAZOBACTAM RELATED COMPOUND A ((2S,3S)-2-アミノ-3-メチル-3-スルフィノ-4-(1H-1,2,3-トリアゾール-1イル)酪酸)](/CAS/GIF/118175-11-4.gif) |
TAZOBACTAM RELATED COMPOUND A ((2S,3S)-2-アミノ-3-メチル-3-スルフィノ-4-(1H-1,2,3-トリアゾール-1イル)酪酸) |
118175-11-4 |
C7H12N4O4S |
![1,4,8,11-Tetraazacy clotetradecance, 1,4,8-tris[(4 Methylphenyl)sufonyl]-](/CAS/20150408/GIF/104395-69-9.gif) |
1,4,8,11-Tetraazacy clotetradecance, 1,4,8-tris[(4 Methylphenyl)sufonyl]- |
104395-69-9 |
C31H42N4O6S3 |
![(1S)-N-(3S)-1-アザビシクロ[2.2.2]オクト-3-イル-1,2,3,4-テトラヒドロ-1-ナフタレンカルボキサミド](/CAS/GIF/177793-79-2.gif) |
(1S)-N-(3S)-1-アザビシクロ[2.2.2]オクト-3-イル-1,2,3,4-テトラヒドロ-1-ナフタレンカルボキサミド |
177793-79-2 |
C18H24N2O |
![(E)-セフトリアキソン](/CAS/GIF/92143-31-2.gif) |
(E)-セフトリアキソン |
92143-31-2 |
C18H18N8O7S3 |
![(Z)-シンナリジン](/CAS/GIF/750512-44-8.gif) |
(Z)-シンナリジン |
750512-44-8 |
C26H28N2 |
![5-BroModescyano CitalopraM](/CAS/GIF/64169-39-7.gif) |
5-BroModescyano CitalopraM |
64169-39-7 |
C19H21BrFNO |
![Deschloro Cetirizine Dihydrochloride](/CAS/GIF/83881-54-3.gif) |
Deschloro Cetirizine Dihydrochloride |
83881-54-3 |
C21H26N2O3 |
![DesvancosaMinyl VancoMycin](/CAS/20210111/GIF/101485-50-1.gif) |
DesvancosaMinyl VancoMycin |
101485-50-1 |
C59H62Cl2N8O22 |
![アセトロール](/CAS/GIF/57898-80-3.gif) |
アセトロール |
57898-80-3 |
C14H22N2O3 |
![RAC-クロピドグレル-MP ENDO誘導体](/CAS/GIF/1346598-12-6.gif) |
RAC-クロピドグレル-MP ENDO誘導体 |
1346598-12-6 |
C25H26ClNO6S |
![1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-Methyl-2-nitroethene-1,1-diaMine](/CAS/20140608/GIF/CB82544399.gif) |
1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-Methyl-2-nitroethene-1,1-diaMine |
1331637-48-9 |
C11H22N6O4S2 |
![2′,3′-ジデオキシ-3′-チアシチジン](/CAS/20150408/GIF/134680-32-3.gif) |
2′,3′-ジデオキシ-3′-チアシチジン |
134680-32-3 |
C8H11N3O3S |
![Formoterol O-β-D-Glucuronide](/CAS/GIF/615551-59-2.gif) |
Formoterol O-β-D-Glucuronide |
615551-59-2 |
C25H32N2O10 |
![Mono-POC Tenofovir 6-Isopropyl CarbaMate](/CAS/GIF/1244022-56-7.gif) |
Mono-POC Tenofovir 6-Isopropyl CarbaMate |
1244022-56-7 |
C18H28N5O9P |
![N-Methyl Iso Desloratadine](/CAS/GIF/183198-48-3.gif) |
N-Methyl Iso Desloratadine |
183198-48-3 |
C20H21ClN2 |
![酒石酸イソプロピルエステル](/CAS/GIF/116601-09-3.gif) |
酒石酸イソプロピルエステル |
116601-09-3 |
C7H12O6 |
![Rivaroxaban Impurity 11](/CAS/20180808/GIF/1411775-06-8.gif) |
Rivaroxaban Impurity 11 |
1411775-06-8 |
C14H17N3O4 |
![(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl propionate](/CAS/20200401/GIF/CB83129539.gif) |
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl propionate |
|
C25H35NO3 |
![Flomoxef Impurity 4](/) |
Flomoxef Impurity 4 |
|
|
![Nicardipine Impurity 5](/) |
Nicardipine Impurity 5 |
|
|
![11,11'-(PIPERAZINE-1,4-DIYL)-BIS-8-CHLORO-5H-DIBENZE[B,E][1,4]-DIAZEPINE](/CAS/GIF/263366-81-0.gif) |
11,11'-(PIPERAZINE-1,4-DIYL)-BIS-8-CHLORO-5H-DIBENZE[B,E][1,4]-DIAZEPINE |
263366-81-0 |
C30H24Cl2N6 |
![Sacubitril Impurity 7](/CAS/20180713/GIF/149709-44-4.gif) |
Sacubitril Impurity 7 |
149709-44-4 |
C22H25NO5 |
![Valsartan Impurity 5](/CAS/20180703/GIF/1266616-11-8.gif) |
Valsartan Impurity 5 |
1266616-11-8 |
C18H21N5 |
![Milnacipran Impurity 4](/CAS/20210111/GIF/1353644-49-1.gif) |
Milnacipran Impurity 4 |
1353644-49-1 |
C15H21NO2 |
![2-アミノ-2-(4-ヘプチルフェネチル)-1,3-プロパンジオール](/CAS/20180808/GIF/745767-97-9.gif) |
2-アミノ-2-(4-ヘプチルフェネチル)-1,3-プロパンジオール |
745767-97-9 |
C18H31NO2 |
![Tenofovir Fumarate](/CAS/20180906/GIF/1246812-23-6.gif) |
Tenofovir Fumarate |
1246812-23-6 |
C21H34N5O9P |
![(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/769908-13-6.gif) |
(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
769908-13-6 |
C25H24FNO4 |
![Prucalopride Impurity C](/CAS/20210111/GIF/1599434-55-5.gif) |
Prucalopride Impurity C |
1599434-55-5 |
C17H24ClN3O3 |
![1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20200401/GIF/2205053-60-5.gif) |
1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
2205053-60-5 |
C21H24FN3O4 |
![Brexpiprazole N-Oxide](/CAS/20200515/GIF/1191900-58-9.gif) |
Brexpiprazole N-Oxide |
1191900-58-9 |
C25H27N3O3S |
![2,6-Dibenzyloxyacetophenone](/CAS/20180906/GIF/3886-19-9.gif) |
2,6-Dibenzyloxyacetophenone |
3886-19-9 |
C22H20O3 |
![6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル](/CAS/20180703/GIF/1059630-08-8.gif) |
6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル |
1059630-08-8 |
C14H17BrN2O2 |
![diphenhydramine impurity](/CAS/20180703/GIF/CB83144868.gif) |
diphenhydramine impurity |
|
C17H21NO |
![1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide](/CAS/20180703/GIF/CB83146796.gif) |
1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide |
|
C18H23IN4S |
![2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid](/CAS/20180703/GIF/1657014-33-9.gif) |
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid |
1657014-33-9 |
C16H16N2O3S |
![vildagliptin Impurity O](/CAS/20200611/GIF/2253194-12-4.gif) |
vildagliptin Impurity O |
2253194-12-4 |
C12H18N4O2 |
![methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/38990-17-9.gif) |
methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
38990-17-9 |
C21H26N2O3 |
![Canagliflozin Impurity 17](/CAS/20210111/GIF/1951467-28-9.gif) |
Canagliflozin Impurity 17 |
1951467-28-9 |
C24H23FO6S |
![Canagliflozin Impurity 22](/) |
Canagliflozin Impurity 22 |
|
|
![Carfilzomib Impurity 3](/) |
Carfilzomib Impurity 3 |
|
|
![Dolutegravir Impurity 4](/) |
Dolutegravir Impurity 4 |
|
|
![Febuxostat Impurity 20](/) |
Febuxostat Impurity 20 |
|
|
![Lenvatinib Impurity 1](/) |
Lenvatinib Impurity 1 |
|
|
![methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20211123/GIF/83508-82-1.gif) |
methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
83508-82-1 |
C21H26N2O3 |
![4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester](/CAS/20180703/GIF/1941177-45-2.gif) |
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester |
1941177-45-2 |
C29H37N7O3 |
![Cabozantinib impurity 1](/CAS/20200611/GIF/748707-58-6.gif) |
Cabozantinib impurity 1 |
748707-58-6 |
C17H16N2O3 |
![Amlodipine Impurity 19](/CAS/20180703/GIF/CB83159169.gif) |
Amlodipine Impurity 19 |
|
C26H31ClN2O8S |
![Amlodipine Impurity 9](/CAS/20180703/GIF/CB83159174.gif) |
Amlodipine Impurity 9 |
90445-05-9 |
C26H31ClN2O8S |
![Clopidogrel Impurity 7](/CAS/20180601/GIF/444728-13-6.gif) |
Clopidogrel Impurity 7 |
444728-13-6 |
C15H15ClN2OS |
![Rivaroxaban Impurity 36](/CAS/20210305/GIF/1770812-39-9.gif) |
Rivaroxaban Impurity 36 |
1770812-39-9 |
C19H17Cl2N3O5S |
![(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate](/CAS/20180601/GIF/1111177-24-2.gif) |
(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate |
1111177-24-2 |
C20H23N5O2 |
![Clopidogrel Impurity C](/CAS/20180601/GIF/1346605-15-9.gif) |
Clopidogrel Impurity C |
1346605-15-9 |
C16H18ClNO2S |
![Nilotinib genotoxic impurity 2](/CAS/20180906/GIF/1157857-29-8.gif) |
Nilotinib genotoxic impurity 2 |
1157857-29-8 |
C19H15F3N4O3 |
![N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン](/CAS/20180808/GIF/1453221-45-8.gif) |
N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン |
1453221-45-8 |
C35H41F6N3O6 |
![Gliclazide Impurity E](/) |
Gliclazide Impurity E |
|
|
![Ethyl 1-butanesulfonate](/CAS/20180601/GIF/2374-68-7.gif) |
Ethyl 1-butanesulfonate |
2374-68-7 |
C6H14O3S |
![OLANEXIDINE intermediate](/CAS/20180808/GIF/60852-95-1.gif) |
OLANEXIDINE intermediate |
60852-95-1 |
C10H20N4 |
![1H-Isoindole, octahydro-, trans-](/CAS/20180601/GIF/10479-63-7.gif) |
1H-Isoindole, octahydro-, trans- |
10479-63-7 |
C8H15N |
![1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI)](/CAS/20180601/GIF/155272-03-0.gif) |
1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |
155272-03-0 |
C18H20N4O4 |
![Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)-](/CAS/20180601/GIF/181289-34-9.gif) |
Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)- |
181289-34-9 |
C9H17NO3 |
![4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate](/CAS/20180601/GIF/65141-48-2.gif) |
4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate |
65141-48-2 |
C8H10N4O7 |
![2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE](/CAS/GIF/91219-90-8.gif) |
2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE |
91219-90-8 |
C11H15NO3 |
![4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE](/CAS/GIF/112809-52-6.gif) |
4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE |
112809-52-6 |
C17H11N5 |
![Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)-](/CAS/20180601/GIF/93239-37-3.gif) |
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
93239-37-3 |
C24H30O5 |
![Tadalafil EP impurity E](/) |
Tadalafil EP impurity E |
|
|
![4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine](/CAS/20200611/GIF/134965-85-8.gif) |
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine |
134965-85-8 |
C12H7ClN6 |
![(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile](/CAS/GIF/914070-99-8.gif) |
(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile |
914070-99-8 |
C7H11N3O |
![1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea](/CAS/20180601/GIF/1388858-78-3.gif) |
1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
1388858-78-3 |
C19H23FN2O2 |
![1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one](/CAS/20200401/GIF/220182-11-6.gif) |
1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one |
220182-11-6 |
C10H20N4O |
![Ropivacaine EP Impurity D](/CAS/20200611/GIF/98626-59-6.gif) |
Ropivacaine EP Impurity D |
98626-59-6 |
C16H24N2O |
![Bendamustine Impurity 16](/CAS/20200611/GIF/914626-65-6.gif) |
Bendamustine Impurity 16 |
914626-65-6 |
C19H18N6O4 |
![(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride](/CAS/20180601/GIF/959392-22-4.gif) |
(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride |
959392-22-4 |
C18H19NOS |